NB-4746

Asset

Inhibits SARM1.

Stage
Phase 1
Modality
Small molecule
Target
NAD+ metabolism
2
Indications
1
Trial
1
Developer

Indications

2

In the full profile

  • Targets and what it contains2
  • Owner and partners1
  • Trials1
  • Evidence for its targets2
  • Competitors12
  • Signals1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets